Transition of patients with interstitial lung disease from paediatric to adult care

Václav Koucký1, Petr Pohunek1, Martina Vašáková2

  • 1Paediatric Pulmonology, Paediatric Dept, 2nd Faculty of Medicine, Charles University in Prague and University Hospital Motol, Prague, Czech Republic.

ERJ Open Research
|June 10, 2021
PubMed

Insights

Transitioning children with interstitial lung disease to adult care is inconsistent and inadequate across most centers. A new model procedure is proposed to improve patient information transfer and preparation for adult care.

Area of Science:

  • Medical Research
  • Public Health
  • Pediatric Pulmonology

Background:

  • The European Cooperation in Science and Technology (COST) Action CA16125 established a network for translational research in interstitial lung diseases (ILDs).
  • Working Group 5 specifically addressed the critical transition of pediatric patients with ILDs to adult care systems.
  • Current transition processes are often fragmented, lacking standardized protocols for information exchange and patient preparation.

Purpose of the Study:

  • To evaluate the existing systems for transitioning pediatric patients with ILDs to adult care.
  • To identify deficiencies and inconsistencies in current transition practices.
  • To develop a model procedure to standardize and improve the transition process.

Main Methods:

  • A survey was conducted among members of COST Action CA16125 Working Group 5 and affiliated specialists.
  • The survey assessed current transition practices, information transfer, and patient preparation protocols.
  • Analysis of survey data identified variability and inadequacy in existing transition systems.

Main Results:

  • The survey revealed highly variable and inadequate transition systems for pediatric ILD patients to adult care in most centers.
  • Most centers lack established, consistent procedures for information transfer and patient preparation.
  • Significant deficiencies were noted in preparing patients for the shift to adult specialists and teams.

Conclusions:

  • Immediate action is required to address the identified shortcomings in pediatric to adult ILD care transition.
  • A model procedure for transition has been developed, drawing on best practices from centers with established pathways.
  • The proposed model aims to ensure a smoother, more effective transition for patients with ILDs.

Related Concept Videos

Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
55
Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.8K
Pneumonia I: Introduction01:30

Pneumonia I: Introduction

Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
450
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
68
Chronic Obstructive Pulmonary Disease-V: Management01:29

Chronic Obstructive Pulmonary Disease-V: Management

Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
2.8K
Pneumonia IV: Management01:28

Pneumonia IV: Management

The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
536